1. International Diabetes Federation . IDF Diabetes Atlas. 9th ed. International Diabetes Federation; 2019.
Google Scholar2. Moore, T, McDonald, M, McHugh-Dillon, H, West, S. Community Engagement: A key Strategy for Improving Outcomes for Australian Families. Vol. 39. Child Family Community Australia: Information Exchange; 2016.
Google Scholar3. American Diabetes Association . Standards of medical care in diabetes-2020 abridged for primary care providers. Clin Diabetes. 2020;38:10-38.
Google Scholar | Crossref | Medline4. Sacerdote, C, Ricceri, F, Rolandsson, O, et al. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int J Epidemiol. 2012;41:1162-1173.
Google Scholar | Crossref | Medline5. Almalki, TM, Almalki, NR, Balbaid, K, Alswat, K. Assessment of diabetes knowledge using the Michigan brief diabetes knowledge test among patients with type 2 diabetes mellitus. J Endocrinol Metab. 2017;7:185-189.
Google Scholar | Crossref6. Morisky, DE, Green, LW, Levine, DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
Google Scholar | Crossref | Medline | ISI7. Allam, MM, El-Zawawy, HT, Ibrahim Ismail, I, Ghazy, RM. Cross-Cultural reliability of an Arabic version of the self-efficacy for managing chronic disease 6-item scale in Arab patients with Diabetes mellitus. Prim Care Diabetes. 2020;14:305-310.
Google Scholar | Crossref | Medline8. Thayaparan, AJ, Mahdi, E. The patient satisfaction questionnaire short form (PSQ-18) as an adaptable, reliable, and validated tool for use in various settings. Med Educ Online. 2013;18:21747.
Google Scholar | Crossref | Medline | ISI9. Weinstein, MC, Stason, WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-721.
Google Scholar | Crossref | Medline | ISI10. Stevens, RJ, Kothari, V, Adler, AI, Stratton, IM, Holman, RR; United Kingdom Prospective Diabetes Study (UKPDS) Group . The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci. 2001;101:671-679.
Google Scholar | Crossref | Medline | ISI11. Pousinho, S, Morgado, M, Falcão, A, Alves, G. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22:493-515.
Google Scholar | Crossref | Medline12. Bukhsh, A, Khan, TM, Lee, SWH, Lee, LH, Chan, KG, Goh, BH. Efficacy of pharmacist based Diabetes educational interventions on clinical outcomes of adults with type 2 Diabetes mellitus: a network meta-analysis. Front Pharmacol. 2018;9:339.
Google Scholar | Crossref | Medline13. Michiels, Y, Bugnon, O, Chicoye, A, et al. Impact of a community pharmacist-delivered information program on the follow-up of type-2 diabetic patients: a cluster randomized controlled study. Adv Ther. 2019;36:1291-1303.
Google Scholar | Crossref | Medline14. Kostoff, MD, Boros, ML, Moorman, JM, Frazee, LA. Evaluation of factors associated with achieving glycemic control in a pharmacist-managed diabetes clinic. Am J Ther. 2014;21:234-239.
Google Scholar | Crossref | Medline15. Clifford, RM, Davis, WA, Batty, KT, Davis, TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes study. Diabetes Care. 2005;28:771-776.
Google Scholar | Crossref | Medline | ISI16. Jahangard-Rafsanjani, Z, Sarayani, A, Nosrati, M, et al. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41:127-135.
Google Scholar | SAGE Journals | ISI17. Simpson, SH, Majumdar, SR, Tsuyuki, RT, Lewanczuk, RZ, Spooner, R, Johnson, JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011;34:20-26.
Google Scholar | Crossref | Medline | ISI18. Lee, VW, Choi, LM, Wong, WJ, Chung, HW, Ng, CK, Cheng, FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015;15:178.
Google Scholar | Crossref | Medline19. Huete, L, Manzano-Lista, FJ, Aránguez, I, Fernández-Alfonso, MS. Impact of pharmacist’s intervention on reducing cardiovascular risk in obese patients. Int J Clin Pharm. 2019;41:1099-1109.
Google Scholar | Crossref | Medline20. Omboni, S, Caserini, M. Effectiveness of Pharmacist’s intervention in the management of cardiovascular diseases. Open Heart. 2018;5:e000687.
Google Scholar | Crossref | Medline21. Paulós, CP, Nygren, CEA, Celedón, C, Cárcamo, CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother. 2005;39:939-943.
Google Scholar | SAGE Journals | ISI22. Sarayani, A, Mashayekhi, M, Nosrati, M, et al. Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice. Int J Clin Pharm. 2018;40:345-353.
Google Scholar | Crossref | Medline23. Santschi, V, Chiolero, A, Paradis, G, Colosimo, AL, Burnand, B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35:2706-2717.
Google Scholar | Crossref | Medline | ISI24. Reeves, L, Robinson, K, McClelland, T, Adedoyin, CA, Broeseker, A, Adunlin, G. Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials. J Pharm Pract. 2021;34:480-492.
Google Scholar | SAGE Journals | ISI25. Watkins, VA, Michaels, NM, Jackson, DL, Rhodes, LA, Marciniak, MW. The effect of community pharmacist-led health coaching on clinical outcomes. J Am Pharm Assoc. 2020;60:S65-S69.
Google Scholar | Crossref26. DeCastro, M, Fuchs, F, CostaSantos, M, et al. Pharmaceutical care program for patients with uncontrolled hypertension: report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens. 2006;19:528-533.
Google Scholar | Crossref | Medline27. Korcegez, EI, Sancar, M, Demirkan, K. Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from northern Cyprus: a randomized controlled trial. J Manag Care Spec Pharm. 2017;23:573-582.
Google Scholar | Crossref | Medline28. Turnacilar, M, Sancar, M, Apikoglu-Rabus, S, Hursitoglu, M, Izzettin, FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci. 2009;31:689-695.
Google Scholar | Crossref | Medline29. Correr, CJ, Melchiors, AC, Fernandez-Llimos, F, Pontarolo, R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33:273-280.
Google Scholar | Crossref | Medline30. Abaza, H, Marschollek, M. SMS education for the promotion of diabetes self-management in low & middle income countries: a pilot randomized controlled trial in Egypt. BMC Public Health. 2017;17:962.
Google Scholar | Crossref | Medline31. Al Haqan, AA, Al-Taweel, DM, Awad, A, Wake, DJ. Pharmacists’ attitudes and role in diabetes management in Kuwait. Med Princ Pract. 2017;26:273-279.
Google Scholar | Crossref | Medline32. Schroeder, MN, Potter, J, DiDonato, K, Lengel, AJ, Powers, MF. Impact of pharmacist follow-up intervention on patient return to a community pharmacy from a convenient care clinic. J Pharm Technol. 2017;33:23-30.
Google Scholar | SAGE Journals | ISI33. Pringle, J, Coley, KC. Improving medication adherence: a framework for community pharmacy-based interventions. Integr Pharm Res Pract. 2015;4:175-183.
Google Scholar | Crossref | Medline34. Odegard, PS, Goo, A, Hummel, J, Williams, KL, Gray, SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433-440.
Google Scholar | SAGE Journals | ISI35. Siaw, MYL, Ko, Y, Malone, DC, et al. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial. J Clin Pharm Ther. 2017;42:475-482.
Google Scholar | Crossref | Medline36. Monte, SV, Slazak, EM, Albanese, NP, Adelman, M, Rao, G, Paladino, JA. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care–based collaboration model. J Am Pharm Assoc. 2009;49:200-208.
Google Scholar | Crossref37. Chen, JH, Ou, HT, Lin, TC, Lai, EC, Kao, YH. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm. 2016;38:88-95.
Google Scholar | Crossref | Medline38. Tam-Tham, H, Clement, F, Hemmelgarn, BR, et al. A cost analysis and cost-utility analysis of a Community pharmacist-led intervention on reducing cardiovascular Risk: the Alberta Vascular Risk Reduction Community Pharmacy project (RxEACH). Value Health. 2019;22:1128-1136.
Google Scholar | Crossref | Medline